Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
- 15 September 2021
- journal article
- review article
- Published by Elsevier BV in Ageing Research Reviews
- Vol. 72, 101462
- https://doi.org/10.1016/j.arr.2021.101462
Abstract
No abstract availableThis publication has 461 references indexed in Scilit:
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- Incidence of dementia and cognitive impairment, not dementia in the united statesAnnals of Neurology, 2011
- Adiponectin protects rat hippocampal neurons against excitotoxicityAGE, 2010
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related DisordersBiological Psychiatry, 2010
- Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain AgingJAMA, 2009
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Insulin Receptor Signaling Regulates Synapse Number, Dendritic Plasticity, and Circuit Function In VivoNeuron, 2008
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer diseaseFEBS Letters, 2008
- Leptin and its role in hippocampal synaptic plasticityProgress in Lipid Research, 2006